Yahoo Finance Singapore

The fair value estimate for Sequans Communications has shifted from US$11.25 to US$8.75, a reduction of about 22% in the analyst target. This reset aligns with recent research that balances optimism about the company's internet of things, radio frequency, 5G and licensing potential with caution around execution and timing. Read on to see how this evolving narrative could shape your view on Sequans Communications from here. Analyst Price Targets don't always capture the full story.

BioArctic (OM:BIOA B) drew fresh attention after its recent share move, with the stock gaining 1.7% in the latest session even as performance over the past month remained weaker. The recent uptick comes after a tougher stretch, with the share price down 10.7% over the past month and 5% year to date, while longer term total shareholder returns of 2.1% over one year and 113.8% over five years suggest momentum has softened rather than broken.

Italmobiliare (BIT:ITM) is back on investors' radar after recent price weakness, with the shares closing at €24.60 on 9 October 2026. The move refocuses attention on this Milan-based investment holding group. Recent trading has been softer, with the 90 day share price return down 15.32% and the year to date share price return down 13.23%, while the 1 year total shareholder return has fallen 20.35%.

China Unicom (Hong Kong) has had a strong run over the past few years, yet the share price is now well below recent highs. That mix of long term gains and a sharp reset puts a spotlight on one issue for investors: whether the current valuation is still grounded in the earnings the telecom group is generating. • Over the past 5 years the stock has gained 84.9%, which raises the question of how much of that rise is backed by the underlying profit profile.

Royal Caribbean Cruises has delivered a very strong multi year share price run, and the question now is whether the business is generating enough cash to back up where the stock trades today. • Over the past 3 years the stock has returned about 239%, which puts a lot of weight on the cruise operator's ability to keep turning that recovery into durable cash flows.

PSP Swiss Property has delivered a solid multi year ride for shareholders, and that track record naturally raises the question of whether the current price is still supported by the earnings the business generates today. With the stock around CHF 142.70, the issue for you is whether those earnings comfortably underpin that tag or now have more work to do. • Over the past 5 years, PSP Swiss Property has returned about 42.3%.

Zealand Pharma shares have fallen sharply over the past year, which puts fresh focus on whether the current price still lines up with what the business earns. With sentiment swinging around new obesity and diabetes drugs, the key issue is how much of that story is already reflected in the earnings multiple today.

Delta Air Lines (NYSE:DAL) cut its 2026 profit forecast after fuel costs surged to record levels, despite strong revenue. • Management linked the heavier fuel bill to external factors such as geopolitical risks affecting global energy supply chains. • The airline reiterated that demand for travel remains robust even as it adjusts guidance to reflect higher operating expenses.

Implantica (OM:IMP A SDB) just cleared a major commercial hurdle. RefluxStop received strong interest at the American Foregut Society 2026 meeting, marking an early milestone in the device's United States rollout. Implantica's recent buzz around RefluxStop comes after a choppy stretch for the shares, with a 7 day share price return that declined 14.1%, a year to date gain of 24.95%, and a 3 year total shareholder return of about 3.4x, pointing to long term momentum despite near term volatility.

Tomra Systems (OB:TOM) has drawn investor attention after its recent share price performance. The stock closed at NOK 90.30 on 9 October 2026, with year to date and 1-year total returns both showing clear declines. For Tomra Systems, the recent 1-day share price return of 1.63% sits against a weak backdrop. The 30-day share price return is down 8.32%, and the 1-year total shareholder return has fallen 35.66%, which points to fading momentum rather than a short-term blip.